Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study - Aleman, S; Brunetto, M; Blank, A; Andreone, P; Bogomolov, P; Chulanov, V; Mamonova, N; Geyvandova, N; Morozov, V; Sagalova, O; Stepanova, T; Deterding, K; Lichtman, A; Mercier, R-C; Manuilov, D; Arterburn, S; Schulze zur Wiesch, J; Cornberg, M; Zeuzem, S; Lampertico, P; Wedemeyer, H (Zeitschrift für Gastroenterologie, 2025)